## **Core Concept**
Hepatitis B e-antigen (HBeAg) is a marker of hepatitis B virus (HBV) replication. Its presence in the serum indicates that the virus is actively replicating and the patient is infectious. HBeAg is a soluble antigen that appears in the serum during the window period between the disappearance of HBsAg (hepatitis B surface antigen) and the appearance of anti-HBe (antibody to HBeAg).

## **Why the Correct Answer is Right**
The presence of HBeAg in the serum of a patient with hepatitis B indicates active viral replication. This is because HBeAg is a marker of HBV replication and high viral load. Patients with HBeAg-positive hepatitis B have a higher risk of transmitting the virus to others and are more likely to progress to chronic liver disease, cirrhosis, and hepatocellular carcinoma.

## **Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the presence of HBeAg does not directly indicate recovery or immunity. Instead, it suggests ongoing viral replication.
* **Option B:** This option is incorrect because HBeAg is not a marker of viral latency; rather, it indicates active viral replication.
* **Option C:** Not applicable as we do not see the actual options.
* **Option D:** This option might suggest an alternative interpretation, but without specifics, we focus on why the correct answer is correct.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of HBeAg correlates with high HBV DNA levels and increased infectivity. Patients with HBeAg-positive chronic hepatitis B are considered to be in an **HBeAg-positive chronic infection** or **HBeAg-positive chronic hepatitis** phase, which is associated with a higher risk of liver damage and transmission.

## **Correct Answer:** . Active viral replication.